NVS News and Press, Novartis AG

2026-07-09 12:32:04 ET Choosing between Novartis AG (NYSE:NVS) and Teva Pharmaceutical Industries (NYSE:TEVA) requires weighing the stability of an established innovator against the potential of a generic specialist undergoing a significant turnaround. Novartis is a powe...

2026-07-08 17:12:48 ET More on Big Pharma Johnson & Johnson: Stronger Fundamentals, But Too Much Optimism Novo Nordisk Loses Its Edge, And I'm Downgrading Novartis' Pipeline Building Continues, Pelacarsen Readout Coming Soon Moderna appoints Michael McDon...

2026-07-08 14:46:06 ET Shares of pure-play cell therapy concern Legend Biotech Corporation ( LEGN ) recently jumped 42% on news that its early-stage CAR-T cell candidate LB2501 showed promise against non-Hodgkin lymphoma. This somewhat stemmed a seven-month, 64% decline (July 20...

2026-07-07 13:36:09 ET Investment Thesis The current market is quite interesting. It seems to struggle to figure out which way to go as it is caught up in dynamics like war escalation vs. de-escalation, oil price shocks, rates reduction vs. hiking, earnings growth of mega caps vs. d...

2026-07-07 08:40:52 ET For the last few years, Novartis’ ( NVS ) growth strategy was organic growth coupled with what it calls “value-creating bolt-ons.” In other words, this is a business development strategy that involves in-licensing deals or small acquis...

2026-07-06 03:15:33 ET ... Read the full article on Seeking Alpha For further details see: Novartis strikes $1.5B deal for UK biotech Myricx Bio

2026-07-04 08:00:00 ET The last time I spoke about Novartis ( NVS ) it was with a Seeking Alpha article entitled " Novartis: Synnovation Deal And 8% Full-Year 2025 Sales Growth ." With respect to this article, I mentioned that the company had achieved full-year 2025 sales gr...

2026-07-02 14:20:44 ET More on Novartis Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely Novartis: H2 Pipeline Readouts Matter, But Valuation Leaves Limited Upside Novartis AG (NVS) Q1 2026 Earnings Call Transcript Novartis and A...

2026-06-30 09:03:16 ET Thesis and Something of a Personal Disclaimer I have been covering Vertex Pharmaceuticals Incorporated ( VRTX ) for over 18 months as a Seeking Alpha analyst and been an investor since 2020. Moreover, as someone with cystic fibrosis ((CF)), I have ...

2026-06-25 11:33:44 ET Investment Overview The privately held biotech Antares Therapeutics announced yesterday that it had struck a deal with Swiss Pharma giant Novartis AG ( NVS ): to discover, develop and commercialize small molecule therapies against promising b...